Back to search
Find a Tender
AWARD
Complete
EYLEA 3.6MG/90MICROLITRE SOLUTION FOR INJECTION
Published Today
10 Nov 2026
- Primary CPV
-
33600000 *
Pharmaceutical products
- Location
- 🇬🇧 Northern Ireland
- Value
- £175,268
- Contract
-
6 months Duration
10/11/2026 30/04/2027
- Contract Types
-
33 *Medical equipment, pharmaceuticals & per...Full CPV Breakdown
- SME suitable
- Not stated
Publisher Address
Altnagelvin Area Hospital, Glenshane Road, Londonderry, BT47 6SB, United Kingdom · UKN
Contact
Br•••••
Upgrade to Pro to see
In•••••
Upgrade to Pro to see
02•••••
Upgrade to Pro to see
Award Criteria
Not specified
Related tenders
Western Health & Social Care Trust
All notices from this publisher Same CPV code
33600000 *
All notices with this CPV code
Reference: WT-PHARM-2026-09
Supply of Eylea Brand of AFLIBERCEPT 40 mg/ml solution for injection in pre-filled syringe to meet clinical need in the Western Trust until 30/04/2027.
Awarded to
Full CPV breakdown
- 33600000 — Pharmaceutical products (primary)
Notice details
- Buyer type
- Central government
- Competition
- Direct award (no competition)
- Contract type
- Goods
- Winning supplier
- Large company
- Procurement method
- Direct award
- Main category
- Goods
- Legal basis
- UKPGA 2023/54
- Notice status
- Complete
- Award status
- Active
- Covered by GPA
- Yes
- Language
- EN
- Published
- 10 Nov 2026 10:06
- OCID
- ocds-h6vhtk-0792e0
- Notice ID
- WT-PHARM-2026-09
Organisations on this notice
Supplier Large
400 South Oak Way, Reading, RG2 6AD, United Kingdom
an•••••
Upgrade to Pro to see
GB-COH 00935048
Full notice record
55 detailsEverything the publisher included in this notice, organised by section. Contact details hidden: upgrade to Pro to see
Organisations
| Party 1 › Name | Western Health & Social Care Trust |
| Party 1 › Address › Street | Altnagelvin Area Hospital, Glenshane Road |
| Party 1 › Address › Town / city | Londonderry |
| Party 1 › Address › Postcode | BT47 6SB |
| Party 1 › Address › Country | GB |
| Party 1 › Address › Country | United Kingdom |
| Party 1 › Address › Region (NUTS) | UKN0A |
| Party 1 › Role | buyer |
| Party 1 › Classification › Classification 1 › Description | Public authority - central government |
| Party 1 › Classification › Classification 2 › Description | Northern Irish devolved regulations apply |
| Party 2 › Name | BAYER PUBLIC LIMITED COMPANY |
| Party 2 › Address › Street | 400 South Oak Way |
| Party 2 › Address › Town / city | Reading |
| Party 2 › Address › Postcode | RG2 6AD |
| Party 2 › Address › Country | GB |
| Party 2 › Address › Country | United Kingdom |
| Party 2 › Address › Region (NUTS) | UKJ11 |
| Party 2 › Role | supplier |
| Party 2 › Link | http://www.bayer.co.uk |
| Party 2 › Business size | large |
| Party 2 › VCSEs | No |
| Party 2 › Public service mission organisation | No |
| Party 2 › Sheltered workshop | No |
Buyer
| Name | Western Health & Social Care Trust |
Tender
| Title | EYLEA 3.6MG/90MICROLITRE SOLUTION FOR INJECTION |
| Description | Supply of Eylea Brand of AFLIBERCEPT 40 mg/ml solution for injection in pre-filled syringe to meet clinical need in the Western Trust until 30/04/2027. |
| Status | complete |
| Procedure type | direct |
| Procedure | Direct award |
| Reason for this procedure | Continuity of patient care is required whilst clinicians complete assessment of the potential introduction of the contracted aflibercept biosimilar comparator. Established patients are currently treated with Eylea under existing treatment regimens. Continued supply of Eylea is required pending completion of clinical review, approval of any switching strategy, and implementation decisions. |
| Covered by | GPA |
| Lot › Status | complete |
| Document › Document type | Conflict of interest |
| Document › Description | Not published |
Awards
| Status | active |
| Category | goods |
| Supplier › Name | BAYER PUBLIC LIMITED COMPANY |
| Item › CPV › Description | Pharmaceutical products |
| Item › Delivery › Region (NUTS) | UKN |
| Item › Delivery › Country | GB |
| Item › Delivery › Country | United Kingdom |
Contracts
| Title | AFLIBERCEPT 40 mg/ml solution for injection in pre-filled syringe |
| Status | active |
| Contract period › Start | 10 Nov 2026 |
| Contract period › End | 30 Apr 2027 |
| Value › Value incl. VAT | £210,321.11 |
| Value › Value | £175,267.59 |
| Value › Currency | GBP |
| Above threshold | Yes |
| Signed | 27 Oct 2026 |
| No Agreed Metrics Rationale | KPIs have not been set as this is a temporary arrangement to maintain continuity of patient care and medicine supply whilst clinical assessment of an alternative contracted product is completed. Contract performance will be monitored through routine supplier performance and supply assurance processes. |
| Document › Document type | Contract notice |
| Document › Description | Contract details notice on Find a Tender |
| Document › Link | https://www.find-tender.service.gov.uk/Notice/106519-2026 |
| Document › Published | 10 Nov 2026 |